Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Director William Grieco sold 2,000 shares of the business’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $51.71, for a total value of $103,420.00. Following the transaction, the director now directly owns 45,013 shares in the company, valued at approximately $2,327,622.23. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

William Grieco also recently made the following trade(s):

  • On Friday, June 16th, William Grieco sold 2,000 shares of Acadia Healthcare stock. The stock was sold at an average price of $45.42, for a total value of $90,840.00.

Shares of Acadia Healthcare Company, Inc. (NASDAQ ACHC) opened at 51.68 on Thursday. Acadia Healthcare Company, Inc. has a 12-month low of $32.54 and a 12-month high of $54.34. The stock has a market cap of $4.54 billion, a P/E ratio of 567.91 and a beta of 1.15. The company has a 50 day moving average price of $50.66 and a 200 day moving average price of $44.98.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. During the same period last year, the company posted $0.73 earnings per share. The firm’s revenue was down 5.4% compared to the same quarter last year. Analysts anticipate that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/08/17/insider-selling-acadia-healthcare-company-inc-achc-director-sells-103420-00-in-stock.html.

Several hedge funds have recently made changes to their positions in ACHC. Falcon Point Capital LLC acquired a new stake in shares of Acadia Healthcare during the first quarter worth about $16,792,000. Monarch Partners Asset Management LLC acquired a new stake in shares of Acadia Healthcare during the first quarter worth about $16,079,000. Jennison Associates LLC raised its stake in shares of Acadia Healthcare by 6.3% in the first quarter. Jennison Associates LLC now owns 885,116 shares of the company’s stock worth $38,591,000 after buying an additional 52,158 shares during the last quarter. Emerald Advisers Inc. PA raised its stake in shares of Acadia Healthcare by 2.3% in the first quarter. Emerald Advisers Inc. PA now owns 85,198 shares of the company’s stock worth $3,715,000 after buying an additional 1,876 shares during the last quarter. Finally, Emerald Mutual Fund Advisers Trust acquired a new stake in shares of Acadia Healthcare during the first quarter worth about $210,000.

A number of equities research analysts have commented on the company. UBS AG restated a “positive” rating and issued a $60.00 target price (up previously from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Deutsche Bank AG lifted their target price on Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, July 31st. Craig Hallum restated a “buy” rating and issued a $65.00 target price (up previously from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. BidaskClub downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, Zacks Investment Research downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. Five research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Acadia Healthcare has a consensus rating of “Buy” and a consensus target price of $59.21.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Insider Buying and Selling by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.